John E. Park

5.7k total citations · 1 hit paper
16 papers, 4.6k citations indexed

About

John E. Park is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, John E. Park has authored 16 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 8 papers in Cancer Research and 6 papers in Molecular Biology. Recurrent topics in John E. Park's work include Peptidase Inhibition and Analysis (8 papers), Protease and Inhibitor Mechanisms (6 papers) and Neuropeptides and Animal Physiology (3 papers). John E. Park is often cited by papers focused on Peptidase Inhibition and Analysis (8 papers), Protease and Inhibitor Mechanisms (6 papers) and Neuropeptides and Animal Physiology (3 papers). John E. Park collaborates with scholars based in Germany, United States and Austria. John E. Park's co-authors include Paul G. Arrigg, Van Hung Nguyen, Napoleone Ferrara, Lloyd Paul Aiello, Mami Iwamoto, Bruce A. Keyt, Lloyd M. Aiello, Hagen Thieme, George L. King and Henry Jampel and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

John E. Park

16 papers receiving 4.5k citations

Hit Papers

Vascular Endothelial Growth Factor in Ocular Fluid of Pat... 1994 2026 2004 2015 1994 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
    1994 3.0k citations Lloyd Paul Aiello, Robert L. Avery et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John E. Park Germany 13 2.3k 1.7k 1.6k 1.0k 685 16 4.6k
Ella Ioffe United States 16 577 0.3× 2.3k 1.4× 490 0.3× 768 0.8× 643 0.9× 24 3.6k
Elena Burova Russia 20 441 0.2× 2.1k 1.2× 436 0.3× 632 0.6× 500 0.7× 52 3.4k
Yoshihiko Usui Japan 31 1.8k 0.8× 822 0.5× 627 0.4× 437 0.4× 175 0.3× 183 3.7k
Sandro De Falco Italy 34 403 0.2× 1.6k 1.0× 392 0.2× 435 0.4× 407 0.6× 69 3.0k
Hiroyuki Namba Japan 39 133 0.1× 2.2k 1.3× 408 0.3× 1.6k 1.6× 618 0.9× 153 4.7k
R.R. Weichselbaum United States 28 139 0.1× 1.8k 1.0× 724 0.4× 1.2k 1.2× 659 1.0× 64 3.5k
Ingrid Struman Belgium 35 340 0.2× 2.3k 1.4× 154 0.1× 341 0.3× 1.3k 1.9× 64 4.0k
Susannah Waxman United States 33 313 0.1× 2.9k 1.7× 210 0.1× 501 0.5× 410 0.6× 97 4.0k
Ilse M. C. Vogels Netherlands 31 310 0.1× 1.0k 0.6× 207 0.1× 321 0.3× 281 0.4× 61 2.3k
Stela Gengrinovitch Israel 6 143 0.1× 2.5k 1.5× 194 0.1× 698 0.7× 826 1.2× 11 3.5k

Countries citing papers authored by John E. Park

Since Specialization
Citations

This map shows the geographic impact of John E. Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John E. Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John E. Park more than expected).

Fields of papers citing papers by John E. Park

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John E. Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John E. Park. The network helps show where John E. Park may publish in the future.

Co-authorship network of co-authors of John E. Park

This figure shows the co-authorship network connecting the top 25 collaborators of John E. Park. A scholar is included among the top collaborators of John E. Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John E. Park. John E. Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Theis, Torsten, et al.. (2025). Transcriptional signature of rapidly responding NK cells reveals S1P5 and CXCR4 as anti-tumor response disruptors. Scientific Reports. 15(1). 10769–10769. 1 indexed citations
2.
Michelfelder, Stefan, Felix Schiele, Sebastian Kreuz, et al.. (2021). Development of a Bispecific Antibody-Based Platform for Retargeting of Capsid Modified AAV Vectors. International Journal of Molecular Sciences. 22(15). 8355–8355. 11 indexed citations
3.
Blech, Michaela, Daniel Seeliger, Barbara Kistler, et al.. (2012). Molecular structure of human GM-CSF in complex with a disease-associated anti-human GM-CSF autoantibody and its potential biological implications. Biochemical Journal. 447(2). 205–215. 13 indexed citations
4.
Baum, Patrick, Ramona Schmid, Carina Ittrich, et al.. (2010). Phenocopy – A Strategy to Qualify Chemical Compounds during Hit-to-Lead and/or Lead Optimization. PLoS ONE. 5(12). e14272–e14272. 33 indexed citations
5.
Roth, Gerald J., Armin Heckel, Matthias Grauert, et al.. (2010). Design, Synthesis, and Evaluation of Indolinones as Inhibitors of the Transforming Growth Factor β Receptor I (TGFβRI). Journal of Medicinal Chemistry. 53(20). 7287–7295. 30 indexed citations
6.
Holden, Lisa, et al.. (2006). Relationship of dairy producer management styles to overall return on assets. TigerPrints (Clemson University). 44(6). 2 indexed citations
7.
Chaudhary, Nveed, Andreas Schnapp, & John E. Park. (2006). Pharmacologic Differentiation of Inflammation and Fibrosis in the Rat Bleomycin Model. American Journal of Respiratory and Critical Care Medicine. 173(7). 769–776. 294 indexed citations
8.
Lee, Fook-Thean, Pilar Garin‐Chesa, John E. Park, et al.. (2003). Expression and targeting of human fibroblast activation protein in a human skin/severe combined immunodeficient mouse breast cancer xenograft model.. PubMed. 2(8). 729–37. 28 indexed citations
9.
Huber, Margit A., Roland Schubert, Ralf Uwe Peter, et al.. (2003). Fibroblast Activation Protein: Differential Expression and Serine Protease Activity in Reactive Stromal Fibroblasts of Melanocytic Skin Tumors. Journal of Investigative Dermatology. 120(2). 182–188. 136 indexed citations
10.
Christian, Sven, Horst Ahorn, Andreas Koehler, et al.. (2001). Molecular Cloning and Characterization of Endosialin, a C-type Lectin-like Cell Surface Receptor of Tumor Endothelium. Journal of Biological Chemistry. 276(10). 7408–7414. 127 indexed citations
11.
12.
Christian, Sven, Horst Ahorn, Maria Novatchkova, et al.. (2001). Molecular Cloning and Characterization of EndoGlyx-1, an EMILIN-like Multisubunit Glycoprotein of Vascular Endothelium. Journal of Biological Chemistry. 276(51). 48588–48595. 47 indexed citations
13.
Levy, Miriam, Geoffrey W. McCaughan, Catherine A. Abbott, et al.. (1999). Fibroblast Activation Protein: A Cell Surface Dipeptidyl Peptidase and Gelatinase Expressed by Stellate Cells At the Tissue Remodelling Interface in Human Cirrhosis. Hepatology. 29(6). 1768–1778. 275 indexed citations
14.
Park, John E., et al.. (1999). Fibroblast Activation Protein, a Dual Specificity Serine Protease Expressed in Reactive Human Tumor Stromal Fibroblasts. Journal of Biological Chemistry. 274(51). 36505–36512. 466 indexed citations
15.
Enenkel, Barbara, et al.. (1998). Mouse fibroblast‐activation protein. European Journal of Biochemistry. 254(3). 650–654. 59 indexed citations
16.
Aiello, Lloyd Paul, Robert L. Avery, Paul G. Arrigg, et al.. (1994). Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders. New England Journal of Medicine. 331(22). 1480–1487. 3027 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ella Ioffe Breakdown of academic impact, for papers by Elena Burova Breakdown of academic impact, for papers by Yoshihiko Usui Breakdown of academic impact, for papers by Sandro De Falco Breakdown of academic impact, for papers by Hiroyuki Namba Breakdown of academic impact, for papers by R.R. Weichselbaum Breakdown of academic impact, for papers by Ingrid Struman Breakdown of academic impact, for papers by Susannah Waxman Breakdown of academic impact, for papers by Ilse M. C. Vogels Breakdown of academic impact, for papers by Stela Gengrinovitch
Rankless by CCL
2026